Cancer research must focus on how cancer cells evolve, new UK strategy arguesBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4087 (Published 22 July 2016) Cite this as: BMJ 2016;354:i4087
- Susan Mayor
Understanding how cancer cells evolve in individual patients is key to developing more effective treatment strategies to improve long term survival, the UK Institute of Cancer Research has argued in its research strategy for the next five years.
“Cancer evolution is the single biggest challenge we face in creating better treatments for patients,” said Paul Workman, chief executive of the institute, which is based in London.
“We have seen some great advances against cancer, but so often we find that the disease evolves, becoming ever more complex and genetically diverse, and finds ways to resist the effects of therapy,” he explained. “Cancer doesn’t stand still.”
To tackle this challenge, the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial